In the realm of drug development, Annexin V assays are indispensable for preclinical assessments of drug safety. By providing early indicators of apoptosis, these assays help identify potential cytotoxic effects of new compounds. This information can be used to optimize drug formulations, mitigate adverse effects, and enhance the overall safety profile of therapeutic agents.
